Prophase Labs

Prophase Labs Net Debt

The Net Debt of Prophase Labs (PRPH) as of Oct 29, 2026 is 8.53 M USD. In the previous year, Net Debt was 23.90 M USD — a change of -64.31% (lower).

Net Debt

8.53 MUSD

YoY

-64.31%

Last updated:

Net Debt of Prophase Labs is 2025 8.53 M USD. Net Debt of Prophase Labs was 2024 23.90 M USD. It decreases by -64.31% lower compared to the previous year.

The Prophase Labs Net Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt
Date
Net Debt
Jan 1, 2018
-4.65 M USD
Jan 1, 2019
-434,000.00 USD
Jan 1, 2020
6.27 M USD
Jan 1, 2021
-2.61 M USD
Jan 1, 2022
-10.48 M USD
Jan 1, 2023
13.72 M USD
Jan 1, 2024
23.90 M USD
Jan 1, 2025
8.53 M USD
The Prophase Labs Net Debt history
YEARNet DebtYoY
8.53 MUSD-64.31%
23.90 MUSD+74.16%
13.72 MUSD-230.95%
-10.48 MUSD+301.11%
-2.61 MUSD-141.68%
6.27 MUSD-1,544.01%
-434,000.00USD-90.67%
-4.65 MUSD-78.80%
-21.94 MUSD-2,191.33%
1.05 MUSD-629.80%
-198,000.00USD-92.99%
-2.83 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Prophase Labs Stock analysis

What does Prophase Labs do? ProPhase Labs, Inc. generates revenue through the sale of over-the-counter consumer healthcare products and dietary supplements. The company develops and markets TK Supplements, featuring LEGENDZ XL for male sexual enhancement, TRIPLE EDGE XL for daily energy and stamina, and SUPER PROSTAFLOW plus for prostate and urinary health. ORXx Complete, a dietary supplement, and ORXx cough/cold drops are also sold to national wholesalers, distributors, and retail chains including pharmacies and mass merchandise stores. The firm targets health-conscious consumers seeking natural solutions through its OTC drug and supplement lines. Its products are distributed via national wholesalers and retailers such as independent and chain drugstores, food stores, and mass merchandise outlets. ProPhase Labs focuses on direct sales to these established retail segments without third-party branding or partnerships. Revenue streams are derived from the consistent demand for male enhancement, energy, and health supplements within the OTC market. The company's product portfolio caters specifically to customers interested in natural health products, with no additional services or digital platforms beyond physical product sales. Prophase Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Prophase Labs stock

Net Debt of Prophase Labs is 8.53 M USD in 2025.

Net Debt of Prophase Labs changed from 23.90 M USD to 8.53 M USD, representing a -64.31% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt Prophase Labs since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's Prophase Labs historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Prophase Labs

All Key Metrics — Prophase Labs